Arkolith/Insider Trading/VKTX/Form 4

Lian Brian

President & CEO, DirectorViking Therapeutics, Inc. (VKTX) · full profile →Form 4 · filed Oct 28, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$1.4M
Net Open-Market Flow
-$1.4M
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 28, 2025Sell(S)39K$35.01$1.4M2.4M
Oct 27, 2025Grant(A)70K—$02.5M

Transaction Codes

S
Open-market sale
A
Grant / award

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-25-254299) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML